in

Chinese stocks: Chinese medicine stock Tianyi Jiahua Shineco, Inc. (TYHT) (1997)

Shineco, Inc. (NASDAQ:TYHT) was founded in 1997, formerly known as Beijing Tenet Jove Technological Development Co., Ltd. Headquartered in Beijing, China, with 425 full-time employees (6/30/2018), it is a joint-stock company legally registered and established in Delaware, United States. It is committed to the research and development and operation of biological health products and has established a distinctive Chinese medicine Industry chain economy.

shinecobiotech

Tianyi Jiahua Shineco, Inc. (TYHT):

Shanggao Co., Ltd. is a joint stock company legally registered and established in Delaware, the headquarter is located in Beijing, China. In China, the company provides health-care herbal products by vertically using its subsidiaries and variable interest entities and horizontally integrating production, distribution and sales channels. The company uses modern engineering technology and biotechnology to mainly produce Chinese herbal medicine products, organic agricultural products and apocynum fiber products.

Shineco, Inc. is committed to the R&D and operation of biological health products, and has established a distinctive traditional Chinese medicine industry chain economy in China, including the cultivation of Chinese medicinal materials, the comprehensive extraction of Chinese medicinal materials, the development and production of extended Chinese medicinal materials, medicines and pharmaceutical raw materials And the five major industrial systems of health product marketing network, physician consultation and service.

Tianyi Jiahua is a manufacturer and seller of Chinese medicinal products, organic agricultural products, apocynum fiber and other health-care herbal products. Shanggao’s current products mainly involve three business areas : medicines and Chinese medicinal products, Apocynum fiber health products, yew and other organic agricultural products.

Shineco, Inc. is a technology-intensive and high-profit enterprise. At present, it has basically formed an industry chain (Chinese medicine industry chain), two core technologies (the preparation method and application of apocynum fiber yarn, and the production of apocynum blended yarn Spinning method), two major industrial projects (500 thousand acres of Chinese medicinal material planting base construction and comprehensive utilization, steam explosion degumming to prepare apocynum fiber and its comprehensive utilization), the enterprise economic structure system is ready for the rapid growth and efficient development of enterprises Conditions.

Tianyi Jiahua’s factories in mainland China produce products, including traditional herbal products, organic agricultural products, specialty textiles and other by-products derived from the native Chinese plant Apocynum. Apocynum venetum grows in Xinjiang, China, and is called “Apocynum venetum” in Chinese. To facilitate distribution, the company has 13 pharmacies and cooperates with 66 other pharmacies in China. Shineco also sells products at the Chinese herbal medicine trading market in Bozhou, Anhui, and its third-party e-commerce platforms such as Taobao, Tmall, and JD.com. Shanggao’s core technology of apocynum venetum business and its derivative applications cover the company’s nine patent fields in China. At present, in China, we hold a patent and method of use (Patent No. 201110429362.9) in the spinning of apocynum fiber. The application of this patent is critical for the high-pressure steam degumming project. Shineco has also obtained eight other patents.

Tianyi Jiahua Shineco, Inc. (TYHT) investment:

Tianyi Jiahua Shineco, Inc. (NASDAQ:TYHT) submitted its IPO prospectus on 3/16/2015, and the listing date was pushed back and forth, the most recent being September 2016. The IPO of Shanggao Company is exclusively underwritten by Huiyin AXA Asset Management Co., Ltd., and it is underwritten by Huaya Financial Group (listed consulting company), Friedman Auditor Firm (listed auditor firm), and Renwen Law Firm (listed law firm ), the United States Kai Fu Law Firm (listed law firm) and Vintage and other institutions, the United States Kai Fu Law Firm formally submitted Shineco to the United States Securities Commission (SEC), Inc. IPO on the Nasdaq main board Application for prospectus.

Shineco, Inc. finally landed on Nasdaq on September 28, 2016 with an IPO price of US$4.50, issuing 1,713,190 shares, raising US$7.71 million, and stock code: TYHT.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all Intels

Anticancer drug company: Celsion Corporation (CLSN) (1982)

Vocational Education Company: Lincoln Educational Services (LINC) (1946)